Advisory Board
Liping is a pioneer in the study of host-microbiome interactions. By applying metagenomics-metabolomics integrated tools and dietary intervention, his lab understands and manipulates gut microbiota to improve human metabolic health and alleviate metabolic diseases such as type 2 Diabetes. He discovered that an endotoxin-producing opportunistic pathogen isolated from an obese human gut could induce obesity in germfree mice. He is both as Chair of Applied Microbiology at Rutgers University and Distinguished Professor of Microbiology at Shanghai Jiao Tong University, and he serves as editor of Microbiology and Microbiome, society fellow and is an advisory board member of several organisations, such as the ISME Journal, the journal Microbiome, the American Academy of Microbiology, CIFAR and AGA.